Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZS18
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,899
Award facts
- Contract value 100% obligated
- $98,898.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $98.9 thousand delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The award, issued on June 5, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of June 27, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $500 million through November 2026, which authorizes the agency to procure a comprehensive portfolio of pharmaceutical products supporting military health facilities nationwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively without set-aside designations. The company's extensive contract history with DLA demonstrates consistent capability in delivering specialty pharmaceuticals, biologics, and medical consumables across diverse product categories. This delivery order for Entyvio, a biologic treatment for inflammatory bowel disease, reflects the company's role in ensuring the Department of Defense maintains access to specialized pharmaceutical therapies required by military healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FZS18?
SPE2DB25FZS18 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 5, 2025.
How much is contract SPE2DB25FZS18 worth?
The government has obligated $98,899 on SPE2DB25FZS18.
Is contract SPE2DB25FZS18 an order under another contract?
Yes. SPE2DB25FZS18 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS18 competed?
The extent of competition for SPE2DB25FZS18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award